Le Lézard
Classified in: Health
Subject: PER

Persona Welcomes Pharmacist Brandi Cole to its Team of Nutritionists


SEATTLE, April 18, 2019 /PRNewswire/ -- Personatm Nutrition, the leading personalized vitamin program, announced today that Brandi Cole, PharmD will join its team of esteemed nutritionists to help support a customer's health and wellness journey. In her role, Cole will provide insight on the pharmaceutical considerations involved with vitamin and supplement recommendations, ensuring Persona's proprietary algorithm that factors more than 850 possible drug nutrient interactions remains current and comprehensive.

Brandi Cole, PharmD, now a part of Persona's nutrition team.

"We are pleased to welcome Brandi to our panel of experts, as her emphasis on personalized care and nutrition education as well as evidence-based medicine align with Persona's core values," said Tamara Bernadot, co-founder and Chief Nutrition Officer (CNO), Persona Nutrition. "Persona continues to be the only vitamin subscription program that cross-references prescription medications before curating a unique vitamin and supplement recommendation. With Brandi's help, we will evolve our nutritional assessment and subscriber care to the next level." 

With more than 12 years of community pharmacy experience, Cole is the staff pharmacist for Stanifer Drugs in New Tazewell, Tennessee, as well as a part-time pharmacist at the Prescription Shop in Harrogate, Tennessee. Cole specializes in evaluating the appropriateness of drug therapy based on patient-specific factors by reviewing medication profiles and screening for appropriate drug selection, optimal dosing, contraindications, side effects and therapeutic outcomes. Cole received her Doctor of Pharmacy from the University of Tennessee Health Science Center College of Pharmacy.

Drug-Nutrient Interactions
Nutrient deficiencies and health conditions often benefit from the use of vitamins and prescription medications, but they can interact. While supplements can be essential to help support the body when taking a medication that causes nutrient depletion, other interactions can occur by direct effect or by changing the metabolism of a drug. Some nutrients compete for the same receptors in the body, and when taken together can reduce absorption or effectiveness.

"I'm excited to join Persona Nutrition as the company is leading the personalized nutrition industry with a truly customized approach that is leaps and bounds above others in terms of drug-nutrient awareness," commented Cole. "A drug supplement interaction could result in a poor pharmacotherapeutic outcome or compromise a person's nutritional status. For these reasons, it is imperative we comprehensively evaluate an individual's medication and supplement regimen to ensure the best results, optimize their therapeutic outcomes and help them reach their wellness goals."

To learn more about Persona Nutrition or to take the free nutritional assessment, please visit www.personanutrition.com.

About Personatm Nutrition
Founded in 2017 as one of the first personalized nutrition subscription startups, Persona has attracted investments from prestigious companies, including L Catterton, Emil Capital Partners and BrandProject. Persona's online assessment is built from its proprietary algorithm, which factors individual needs, lifestyle and prescription medications to deliver a recommendation as unique as each consumer. In 2019, Persona and the leading brand of probiotics, Culturelle®, formed an exclusive partnership to deliver Culturelle® through Persona's personalized subscription service. As proud supporters of Vitamin Angels®, every Persona vitamin pack order provides at least two children who are at risk of malnutrition a full year of vitamins. To learn more, please visit www.personanutrition.com.

 

(PRNewsfoto/Persona)

SOURCE Persona


These press releases may also interest you

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care...

at 07:30
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:30
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received notice of intent...

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...



News published on and distributed by: